Ciprofolxacin Injectable (Iv) 200 mg/100 mL, 400 mg/200 mL Suppliers & Bulk Manufacturers
Available Forms: Injectable (IV)
Available Strengths: 200 mg/100 mL, 400 mg/200 mL
Reference Brands: Cipro(US & EU)
Category: Antibiotics
Ciprofloxacin IV inhibits bacterial DNA gyrase and topoisomerase IV, blocking DNA replication and leading to bacterial cell death. It provides rapid, broad-spectrum activity against severe infections such as sepsis and pneumonia. Benefits include high tissue penetration, quick onset, and effective treatment of serious bacterial infections in hospital settings.
Product Description: Ciprofloxacin IV is approved in the EU and US for severe bacterial infections, including sepsis, pneumonia, and complicated urinary tract infections. In the EU, brands like Cipro are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for ciprofloxacin IV, ensuring adherence to European and US standards for safe, effective treatment of serious bacterial infections.
Ciprofolxacin Injectable (Iv) — third party manufacturing & bulk supply
Ciprofolxacin Injectable (Iv) 200 mg/100 mL, 400 mg/200 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Ciprofolxacin Injectable (Iv) is supplied as Injectable (IV) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Ciprofolxacin Injectable (Iv) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Ciprofolxacin Injectable (Iv) →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Rifaximin
Strength:
100 mg/5 mL, 200 mg, 550 mg
Form: Tablet / Oral Suspension
Reference Brands: Xifaxan (USA), Targaxan (EU), Normix (LATAM)
View Details
Ceftaroline
Strength:
600 mg
Form: Injection
Reference Brands: Teflaro (USA), Zinforo (EU)
View Details
Quick Response Guaranteed | Verified Suppliers
